Physician profile
Lori B Read
NPI 1588938336
$7,265.97
in general payments reported to CMS, 2019-2025
53 companies · $1,464 in 2025
The $1,464 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,589 · 2022: $1,531 · 2023: $1,362 · 2024: $1,320 · 2025: $1,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,116 · Long Term Medical Supply Or Device Loan: $29.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,115.67 |
| Long Term Medical Supply Or Device Loan | $29.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,587.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,045.30 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $441.25 | 2021-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.78 | 2021-2025 | Jardiance, Synjardy |
| Dexcom, INC. | $394.13 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $389.18 | 2021-2025 | Freestyle Libre, Freestyle Insulinx, Freestyle Libre 3 |
| Abbvie INC. | $313.68 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $248.78 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $205.84 | 2021-2025 | |
| Insulet Corporation | $190.21 | 2022-2025 | Omnipod |
| Ibsa Pharma INC. | $168.38 | 2021-2025 | Tirosint, Licart, Flector |
| Merck Sharp & Dohme LLC | $144.98 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $123.27 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $119.44 | 2021-2025 | Minimed 780g, Inceptiv |
| Vivus LLC | $117.19 | 2021-2024 | Qsymia |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $112.02 | 2021-2025 | Strensiq |
| Mannkind Corporation | $102.41 | 2023-2025 | Afrezza |
| Corcept Therapeutics | $100.78 | 2023-2025 | Korlym |
| Ipsen Biopharmaceuticals, INC | $76.27 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $65.61 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $62.27 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $46.15 | 2023-2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $46.10 | 2021-2024 | Farxiga |
| Axsome Therapeutics, INC. | $46.02 | 2022-2023 | Sunosi |
| Amphastar Pharmaceuticals, INC. | $42.45 | 2024-2025 | |
| Ultragenyx Pharmaceutical INC. | $41.17 | 2021-2023 | Crysvita |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.64 | 2021-2023 | Xifaxan, Trulance, Cycloset |
| Embecta Corp. | $40.47 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Madrigal Pharmaceuticals | $37.07 | 2025 | Rezdiffra |
| Verity Pharmaceuticals INC. | $32.93 | 2024 | Tlando |
| Idorsia Pharmaceuticals US INC | $31.19 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $31.16 | 2023-2025 | Nexletol |
| Antares Pharma, INC. | $30.23 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Recordati_rare_diseases_inc. | $29.75 | 2021-2025 | Isturisa |
| Glaxosmithkline, LLC. | $28.54 | 2021-2022 | |
| Becton, Dickinson and Company | $28.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.44 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $27.39 | 2023 | Adthyza, Edarbyclor |
| Chiesi USA, INC. | $23.92 | 2025 | Mycapssa |
| Bausch Health US, LLC | $22.77 | 2021 | |
| Sequel Med Tech, LLC | $18.33 | 2025 | Twiist |
| Averitas Pharma INC. | $16.42 | 2025 | Qutenza |
| Neurocrine Biosciences, INC. | $16.08 | 2024 | |
| Ascendis Pharma Endocrinology INC | $15.22 | 2023 | |
| Pfizer INC. | $15.00 | 2021 | |
| Clarus Therapeutics INC. | $14.96 | 2021 | |
| Tolmar, INC. | $14.77 | 2023 | |
| Amryt Pharma Holdings LTD | $14.64 | 2021 | |
| Acerus Pharmaceuticals Corporation | $14.48 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.63 | 2021 | |
| Cequr Corporation | $13.61 | 2022 | |
| Endo Pharmaceuticals INC. | $13.28 | 2021 | |
| Zealand Pharma US, INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.